Predicting distant recurrence of ER+HER2-breast cancer after 5 years of endocrine therapy: The CTS5-tool validation in real life
dc.contributor.author | Van Cauwenberge, J | en_US |
dc.contributor.author | Sestak, I | en_US |
dc.contributor.author | Punie, K | en_US |
dc.contributor.author | Wildiers, H | en_US |
dc.contributor.author | Floris, G | en_US |
dc.contributor.author | Vergote, I | en_US |
dc.contributor.author | Berteloot, P | en_US |
dc.contributor.author | Van Gorp, T | en_US |
dc.contributor.author | Smeets, A | en_US |
dc.contributor.author | Van Nieuwenhuysen, E | en_US |
dc.contributor.author | Han, S | en_US |
dc.contributor.author | Nevelsteen, I | en_US |
dc.contributor.author | Weltens, C | en_US |
dc.contributor.author | Janssen, H | en_US |
dc.contributor.author | Neven, P | en_US |
dc.date.accessioned | 2020-10-28T14:56:35Z | |
dc.date.available | 2019-09-13 | en_US |
dc.date.issued | 2020-02 | en_US |
dc.identifier.issn | 0008-5472 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67830 | |
dc.title | Predicting distant recurrence of ER+HER2-breast cancer after 5 years of endocrine therapy: The CTS5-tool validation in real life | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1158/1538-7445.SABCS19-P5-06-08 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000527012502337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 80 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1181]